Description: From a session at the 2000 Valuation Actuary Symposium held in Washington DC, September 14-15, 2000 The session provides a brief overview of a variety of financial reporting topics, most of which were discussed in more detail in the subsequent sessions. The overview included topical issues as follows: • National Association of Insurance Commissioners NAIC Life and Health Actuarial Task Force developments and directions • Other NAIC/regulatory development • American Academy of Actuaries AAA/Actuarial Standards Board ASB developments • Financial Accounting Standards Board/Security Exchange Commission FASB/SEC and Generally Accepted Accounting Principles GAAP developments • Tax developments • Reinsurance development • Gramm-Leach-Bliley Financial Modernization Act

Description: Panelists: [1] describe the goals, purposes, and current status of the Society of Actuaries' research into the credit risk of commercial mortgages and private-placement bonds, [2] describe the theory behind the new AVR and IMR and how they function, [3] describe their use from the valuation actuary’s perspective, and [4] discuss the potential impact the AVR/IMR may have on investing and accounting decisions. Session 11 of the 1992 Valuation Actuary Symposium.

Description: Presented at May 2002 Spring Meeting. Discusses recent changes in the Actuarial Opinion and Memorandum Regulation, the ways in which the new requirements can be fulfilled, and the use of asset-adequacy analysis in other areas of the company.

Description: A discussion of the development, key elements, applications, and implementation process of the 2001 CSO Tables for individual life insurance policies for computing minimum reserves, nonforfeiture benefits and tax reserves.

Description: Slides from a session at a meeting of the Society of Actuaries held in San Diego, CA, June 22-23, 2000 This session discusses recent developments within the American Academy of Actuaries and the National Association of Insurance Commissioners with regard to reserving requirements for equity-indexed annuities and life insurance.

Description: From a session at the 2000 Valuation Actuary Symposium held in Washington DC, September 14-15, 2000 Addresses a variety of financial reporting issues of interest to the attendees at a meeting of Valuation Actuaries.

Description: Discusses the MSVR: its purpose, how it has [or has not] met its purpose – especially for a company invested in high-risk securities – how it will be affected by the proposed valuation-law changes, and how to treat it in the actuarial opinion required by New York Regulation 126. From the 1988 Record of Society of Actuaries, Vol. 14, No. 3.

Description: This session is about meeting the needs for financial information in managing an insurance company. Topics include: 1. What are management's basic needs how are they met can financial systems continue to meet the challenge? 2. Are fundamental changes ahead for GAAP reporting? 3. Is it time for mutual companies to provide more meaningful financial information? 4. Can current regulatory reporting meet the needs of the 21st century? 5. Can separate statutory and GAAP systems continue to coexist? 6. Will the United States regulatory environment reduce our global competitiveness? 7. Variance analysis - Why your predictions were wrong - Which variances are acts of God? - Which variances should be blamed on somebody? - How to deal with interest rate fluctuations 8. Market valuation, why? - What questions are being addressed with market valuation

Description: From the 1985 Valuation Actuary Symposium A review of the process involved in making an actuarial opinion and in developing the related actuarial report to management. This was accomplished through a case study approach, specifically covering a universal life product.

Description: From a session at the 2002 Valuation Actuary Symposium, held in Lake Buena Vista, Florida, September 19–20, 2002 Discussion of issues and the impact of current statutory valuation requirements for life insurance policies. Requirements covered include the Actuarial Standard of Practice on XXX, Actuarial Guideline AXXX, and Actuarial Guidelines 36 and 37. Products and issues discussed include nonlevel premium or nonlevel benefit insurance e.g., selective term, universal life with secondary guarantees or shadow accounts, determination of X factors, interpretation issues regarding XXX, variable life, and variable universal life, equity-indexed universal life, and the new CSO mortality table.